Literature DB >> 8977509

Expression of IL-6, IL-8, and RANTES on human bronchial epithelial cells, NCI-H292, induced by influenza virus A.

S Matsukura1, F Kokubu, H Noda, H Tokunaga, M Adachi.   

Abstract

Bronchial epithelial cells are primary sites of airway viral infection, and these cells may play an important role in the pathogenesis of respiratory diseases. It has recently been reported that bronchial epithelial cells express RANTES. RANTES attracts monocytes, T cells, eosinophils, and basophils; it can also activate eosinophils. To determine whether viral infection induces RANTES expression on bronchial epithelial cells, we infected a bronchial epithelial cell line, NCI-H292, with influenza virus A (H3N2). We then examined the concentration of RANTES in the culture medium of infected cells by ELISA and assessed expression of the gene for RANTES by the reverse-transcriptase polymerase chain reaction. We also investigated the concentrations of IL-6, IL-8, and granulocyte-macrophage colony-stimulating factor in the medium of infected cells, because some virus infections have been reported to induce expression of these cytokines on bronchial epithelial cells, but there are few data concerning influenza virus infection. Small amounts of IL-6 and IL-8 were detected in the medium of uninfected cells. RANTES was not detected in the medium of uninfected cells. After influenza virus infection, significant amounts of IL-6, IL-8, and RANTES were released into the culture medium of infected cells, and RANTES messenger RNA was detected from infected cells. Granulocyte-macrophage colony-stimulating factor was not detected in the medium of uninfected and infected cells. These results suggest that influenza virus infection may stimulate production of IL-6, IL-8, and RANTES from human bronchial epithelial cells and that these cytokines may contribute to the pathogenesis of airway inflammatory diseases caused by influenza virus infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8977509     DOI: 10.1016/s0091-6749(96)80195-3

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  53 in total

1.  A spatial model of the efficiency of T cell search in the influenza-infected lung.

Authors:  Drew Levin; Stephanie Forrest; Soumya Banerjee; Candice Clay; Judy Cannon; Melanie Moses; Frederick Koster
Journal:  J Theor Biol       Date:  2016-02-23       Impact factor: 2.691

2.  Cooperative activation of CCL5 expression by TLR3 and tumor necrosis factor-alpha or interferon-gamma through nuclear factor-kappaB or STAT-1 in airway epithelial cells.

Authors:  Tetsuya Homma; Satoshi Matsukura; Takashi Hirose; Tsukasa Ohnishi; Teruaki Kimura; Masatsugu Kurokawa; Koushi Ieki; Miho Odaka; Shintaro Suzuki; Shin Watanabe; Masayuki Sato; Mio Kawaguchi; Robert P Schleimer; Mitsuru Adachi
Journal:  Int Arch Allergy Immunol       Date:  2010-06-04       Impact factor: 2.749

3.  Increased interleukin-6 levels in nasal lavage samples following experimental influenza A virus infection.

Authors:  D Gentile; W Doyle; T Whiteside; P Fireman; F G Hayden; D Skoner
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

4.  Discrete Dynamical Modeling of Influenza Virus Infection Suggests Age-Dependent Differences in Immunity.

Authors:  Ericka Keef; Li Ang Zhang; David Swigon; Alisa Urbano; G Bard Ermentrout; Michael Matuszewski; Franklin R Toapanta; Ted M Ross; Robert S Parker; Gilles Clermont
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

5.  Basic research on virus-induced asthma exacerbation: inhibition of inflammatory chemokine expression by fluticasone propionate.

Authors:  Satoshi Matsukura; Masatsugu Kurokawa; Tetsuya Homma; Shin Watanabe; Shintaro Suzuki; Koushi Ieki; Hiroko Takeuchi; Kyoko Notomi; Robert P Schleimer; Mio Kawaguchi; Fumio Kokubu
Journal:  Int Arch Allergy Immunol       Date:  2013-05-29       Impact factor: 2.749

6.  DAS181, a sialidase fusion protein, protects human airway epithelium against influenza virus infection: an in vitro pharmacodynamic analysis.

Authors:  Gallen B Triana-Baltzer; Maria Babizki; Michael C W Chan; Adam C N Wong; Laura M Aschenbrenner; Erin R Campbell; Qi-Xiang Li; Renee W Y Chan; J S Malik Peiris; John M Nicholls; Fang Fang
Journal:  J Antimicrob Chemother       Date:  2009-11-26       Impact factor: 5.790

7.  Immune dysregulation in severe influenza.

Authors:  Meredith L Heltzer; Susan E Coffin; Kelly Maurer; Asen Bagashev; Zhe Zhang; Jordan S Orange; Kathleen E Sullivan
Journal:  J Leukoc Biol       Date:  2009-06       Impact factor: 4.962

8.  Acute infection with influenza virus enhances susceptibility to fatal pneumonia following Streptococcus pneumoniae infection in mice with chronic pulmonary colonization with Pseudomonas aeruginosa.

Authors:  M Seki; Y Higashiyama; K Tomono; K Yanagihara; H Ohno; Y Kaneko; K Izumikawa; Y Miyazaki; Y Hirakata; Y Mizuta; T Tashiro; S Kohno
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

Review 9.  Respiratory viruses and eosinophils: exploring the connections.

Authors:  Helene F Rosenberg; Kimberly D Dyer; Joseph B Domachowske
Journal:  Antiviral Res       Date:  2009-04-16       Impact factor: 5.970

10.  Influenza H5N1 and H1N1 virus replication and innate immune responses in bronchial epithelial cells are influenced by the state of differentiation.

Authors:  Renee W Y Chan; Kit M Yuen; Wendy C L Yu; Carol C C Ho; John M Nicholls; J S Malik Peiris; Michael C W Chan
Journal:  PLoS One       Date:  2010-01-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.